Tenecteplase for Stroke Thrombolysis Up to 24 Hours? Tenecteplase for Stroke Thrombolysis Up to 24 Hours?
The thrombolytic tenecteplase may have a role in reestablishing blood flow in patients with large-vessel acute ischemic stroke up to 24 hours after stroke onset, a new trial from China suggests.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - February 16, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Stroke Risk Highest Right After COVID Infection Stroke Risk Highest Right After COVID Infection
A new study adds to the mounting evidence linking COVID-19 to increased risk for ischemic stroke and suggests the first 3 days after infection are highest in terms of risk.Medscape Medical News (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - February 15, 2022 Category: Emergency Medicine Tags: Cardiology News Source Type: news
Acute Ischemic Stroke Patients and Risk of Refeeding Syndrome Acute Ischemic Stroke Patients and Risk of Refeeding Syndrome
Results from a retrospective observational study could help recognize patients at high risk for the syndrome and inform nutritional management for individuals suffering this type of stroke.First Look (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - February 15, 2022 Category: Neurology Tags: Neurology & Neurosurgery News Source Type: news
New ERLEADA ® (apalutamide) Analysis Demonstrates Rapid, Deep Prostate-Specific Antigen (PSA) Response in Patients with Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
SAN FRANCISCO, Feb. 14, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new real-world evidence data showing the initiation of ERLEADA® (apalutamide) results in high rates of rapid and deep prostate-specific antigen (PSA) response among patients with metastatic castration-sensitive prostate cancer (mCSPC). In a separate post-hoc analysis of the registrational Phase 3 SPARTAN and TITAN studies, rapid and deep PSA responses with ERLEADA® were associated with improvement in patient-reported outcomes (PROs) related to quality of life, physical wellbeing, pain, and fatigue intensity. The...
Source: Johnson and Johnson - February 14, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Intra-arterial tPA After Stroke Thrombectomy:'Remarkable' Benefit Intra-arterial tPA After Stroke Thrombectomy:'Remarkable' Benefit
Giving intra-arterial thrombolysis after successful thrombectomy for ischemic stroke led to a large increase in excellent neurologic outcomes in CHOICE, a groundbreaking new study.Medscape Medical News (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 11, 2022 Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news
Stroke: People with a common disorder could be ‘three times’ more likely to have a stroke
STROKE is a life-threatening condition that claims hundreds of thousands of lives annually. What's more, those who don't succumb to the condition are often left handicapped. One condition that affects millions in the UK may put individuals in greater peril of suffering an ischaemic stroke. (Source: Daily Express - Health)
Source: Daily Express - Health - February 10, 2022 Category: Consumer Health News Source Type: news
Sex Differences in Presentation of Stroke Sex Differences in Presentation of Stroke
Do men and women differ in their presentation of acute stroke or transient ischemic attack? This review investigated possible gender-related disparities of focal and nonfocal stroke symptoms.Stroke (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 10, 2022 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
Endovascular Therapy Benefits Stroke With Larger Ischemic Core? Endovascular Therapy Benefits Stroke With Larger Ischemic Core?
Results of the RESCUE-JAPAN LIMIT trial suggest that endovascular clot removal could be extended to stroke patients with larger areas of brain ischemia.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - February 9, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Ischemic stroke: The two peculiar sensations felt in your limbs being early warning signs
ISCHEMIC strokes affect roughly 100,000 people in the UK per year. Survival is greatly determined by spotting the early indicators of the impending doom and acting accordingly. (Source: Daily Express - Health)
Source: Daily Express - Health - February 8, 2022 Category: Consumer Health News Source Type: news
ASA: Less Bleeding Seen With Tenecteplase for Ischemic Stroke
FRIDAY, Feb. 4, 2022 -- For patients with ischemic stroke, use of tenecteplase (TNK) for thrombolysis is associated with a lower rate of symptomatic intracranial hemorrhage (sICH) than alteplase (ALT), according to a study presented at the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 4, 2022 Category: Pharmaceuticals Source Type: news
Janssen Data at ASCO GU Demonstrate Longstanding Leadership in Prostate Cancer and Commitment to Advancing Potential New Therapeutic Options for Genitourinary Cancers
Raritan, NJ, Feb. 1, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that 17 presentations will be featured at the 2022 American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium, taking place in San Francisco and virtually from February 17-19. Building on its long-term leadership in prostate cancer, Janssen is committed to advancing innovative treatments and transforming patient experiences, while focusing on research that may drive better outcomes for people across the genitourinary cancer spectrum. Data to be presented include Phase 3 results for the selective ...
Source: Johnson and Johnson - February 1, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news
Ischemic Stroke Rates Higher in Young Women Than Young Men Ischemic Stroke Rates Higher in Young Women Than Young Men
Young women may be at a higher risk of ischemic stroke than young men, a new systematic review shows, representing a ' significant departure from our current scientific understanding, ' researchers say.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - January 27, 2022 Category: Intensive Care Tags: Cardiology News Source Type: news
Among Young Adults, More Women Than Men Have Ischemic Strokes
THURSDAY, Jan. 27, 2022 -- For young adults (aged 35 years or younger), the incidence of ischemic stroke is higher among women than men, according to a review published in the February issue of Stroke.
Michelle H. Leppert, M.D., from the University... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 27, 2022 Category: Pharmaceuticals Source Type: news
New Guidance on Consent in Acute Ischemic Stroke New Guidance on Consent in Acute Ischemic Stroke
The American Academy of Neurology has issued a new position statement on"Consent Issues in the Management of Acute Ischemic Stroke," the first update in more than 20 years.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - January 19, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
AAN Position Statement Addresses Consent Issues in Acute Stroke
WEDNESDAY, Jan. 19, 2022 -- Issues relating to consent for people who have experienced acute ischemic stroke are addressed in an American Academy of Neurology position statement published online Jan. 10 in Neurology.
Justin A. Sattin, M.D., from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 19, 2022 Category: Pharmaceuticals Source Type: news
